These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37999800)

  • 1. What can we learn about acid-base transporters in cancer from studying somatic mutations in their genes?
    White B; Swietach P
    Pflugers Arch; 2024 Apr; 476(4):673-688. PubMed ID: 37999800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid transporters within the solute carrier superfamily: Underappreciated proteins and novel opportunities for cancer therapy.
    Hushmandi K; Einollahi B; Saadat SH; Lee EHC; Farani MR; Okina E; Huh YS; Nabavi N; Salimimoghadam S; Kumar AP
    Mol Metab; 2024 Jun; 84():101952. PubMed ID: 38705513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.
    Bányai L; Trexler M; Kerekes K; Csuka O; Patthy L
    Elife; 2021 Jan; 10():. PubMed ID: 33427197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Solute Carrier Transporters in Glioma Pathology: A Comprehensive Review.
    Anagnostakis F; Kokkorakis M; Markouli M; Piperi C
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities.
    Schlessinger A; Zatorski N; Hutchinson K; Colas C
    Trends Biochem Sci; 2023 Sep; 48(9):801-814. PubMed ID: 37355450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population.
    Mir A; Almudhry M; Alghamdi F; Albaradie R; Ibrahim M; Aldurayhim F; Alhedaithy A; Alamr M; Bawazir M; Mohammad S; Abdelhay S; Bashir S; Housawi Y
    Hum Genet; 2022 Jan; 141(1):81-99. PubMed ID: 34797406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
    Singh M; Afonso J; Sharma D; Gupta R; Kumar V; Rani R; Baltazar F; Kumar V
    Semin Cancer Biol; 2023 May; 90():1-14. PubMed ID: 36706846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiating SLC transporter activity: Emerging drug discovery opportunities.
    Rives ML; Javitch JA; Wickenden AD
    Biochem Pharmacol; 2017 Jul; 135():1-11. PubMed ID: 28214518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocarboxylate transporters: past, present, and future.
    Merezhinskaya N; Fishbein WN
    Histol Histopathol; 2009 Feb; 24(2):243-64. PubMed ID: 19085840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane transporters in cell physiology, cancer metabolism and drug response.
    Alam S; Doherty E; Ortega-Prieto P; Arizanova J; Fets L
    Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 38037877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-expression pattern of SLC transporter genes associated with the immune landscape and clinical outcomes in gastric cancer.
    Zhang Y; Liu Z; Li L; Zeng D; Sun H; Wu J; Zhou R; Liao W
    J Cell Mol Med; 2023 Dec; 27(24):4181-4194. PubMed ID: 37909856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease.
    Schumann T; König J; Henke C; Willmes DM; Bornstein SR; Jordan J; Fromm MF; Birkenfeld AL
    Pharmacol Rev; 2020 Jan; 72(1):343-379. PubMed ID: 31882442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic SLC family genes promote cell proliferation, migration, and invasion in hepatocellular carcinoma.
    Fang X; Liu Y; Xiao W; Zhao N; Zhu C; Yu D; Zhao Y
    Acta Biochim Biophys Sin (Shanghai); 2021 Jul; 53(8):1065-1075. PubMed ID: 34128989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers.
    Bharadwaj R; Jaiswal S; Velarde de la Cruz EE; Thakare RP
    Diseases; 2024 Mar; 12(3):. PubMed ID: 38534987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a novel microscale thermophoresis ligand-binding assay for characterization of SLC solute carriers using oligopeptide transporter PepT1 (SLC15 family) as a model system.
    Clémençon B; Lüscher BP; Hediger MA
    J Pharmacol Toxicol Methods; 2018; 92():67-76. PubMed ID: 29580877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional annotation of solute carrier transporters: implication for drug discovery.
    Dvorak V; Superti-Furga G
    Expert Opin Drug Discov; 2023; 18(10):1099-1115. PubMed ID: 37563933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocarboxylate Transporters (SLC16): Function, Regulation, and Role in Health and Disease.
    Felmlee MA; Jones RS; Rodriguez-Cruz V; Follman KE; Morris ME
    Pharmacol Rev; 2020 Apr; 72(2):466-485. PubMed ID: 32144120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A guide to plasma membrane solute carrier proteins.
    Pizzagalli MD; Bensimon A; Superti-Furga G
    FEBS J; 2021 May; 288(9):2784-2835. PubMed ID: 32810346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutrient transporters: connecting cancer metabolism to therapeutic opportunities.
    Nwosu ZC; Song MG; di Magliano MP; Lyssiotis CA; Kim SE
    Oncogene; 2023 Mar; 42(10):711-724. PubMed ID: 36739364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pan-cancer analysis of whole genomes.
    ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium
    Nature; 2020 Feb; 578(7793):82-93. PubMed ID: 32025007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.